Public-Private India Initiative To Back Cheap Quality Tests Of Patient Drugs
This article was originally published in PharmAsia News
A public-private initiative has approved a pilot project in India that would allow patients to have their drugs tested in government-back laboratories with the initiative's support to keep the costs extremely low.
You may also be interested in...
Third quarter earnings show Gilead’s Immunomedics buy paid off, but filgotinib’s path may narrow. The HIV and HCV franchises picked up from their COVID-19 lull.
Mayo Clinic announces AI-based partnerships with Google and voice-analysis company Vocalis Health this week.
US pharmacy group says that 10 to 12 states have indicated through an informal survey that they do not have the manpower or funding to implement the US FDA’s final MOU on inordinate compounding. They say what is at stake in these states is patient access to compounded medicines.